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Functional Alterations of Ion Channels From Cardiac
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Gracious R. Ross, PhD, Arshad Jahangir, MD
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Institute, Aurora Health Care, Milwaukee, WI

Abstract	In an aged population, cardiovascular disease is the leading cause of fatality and morbidity. Age-related
fibrotic remodeling of the heart contributes to progressive myocardial dysfunction. Cardiac fibroblasts
(CF), responsible for the maintenance of extracellular matrix and fibrosis process, play an important
role in cardiac health and disease. CFs influence myocardial function by their chemical, electrical
and mechanical interactions with cardiomyocytes through extracellular matrix deposition or secretion
of cytokines and growth factors. These, in turn, are modulated by ion channels, macromolecular
pores in the plasma membrane that allow selective ionic fluxes of major ions like K+, Ca2+, Na+ or Cl-,
which affect membrane potential and cellular signal transduction. The importance of ion channels in
modulating various functions of CFs, including proliferation, differentiation, secretion and apoptosis, is
being recognized from recent studies of CFs from animal models and tissue from patients with various
cardiac pathologies. Understanding the role of ion channels in CFs under physiological conditions and
their alterations in age-related cardiac diseases may help facilitate development of novel therapeutic
strategies to limit cardiac fibrosis and its adverse effect on myocardial function. This narrative review
summarizes the knowledge gained thus far on ion channels in CFs and their relationship with cardiac
diseases in human and experimental animal models. (J Patient Cent Res Rev. 2016;3:207-216.)
Keywords

ion channels; cardiac fibroblasts; heart diseases; aging

Cardiovascular disease is the leading cause of morbidity
and mortality in the aged population.1 It is influenced
by age-related fibrotic remodeling of the heart, which
contributes to progressive myocardial dysfunction
as demonstrated in various experimental and clinical
studies.2 Cardiac fibroblasts (CF), responsible for
the maintenance of extracellular matrix and fibrosis
process, form more than 70% of the total heart cell
population and play an important role in cardiac
health and disease. Fibroblasts are mesenchymal cells
that secrete extracellular matrix proteins that provide
structural framework for tissues, such as collagen
and fibronectin, and participate in wound healing
after injury. In addition, CFs influence myocardial
function by their chemical, electrical and mechanical
interactions with cardiomyocytes.3 In response to
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injury, fibroblasts get activated by local cytokines to
migrate and transdifferentiate into more secretory and
contractile myofibroblasts.4 For detailed information
on the role of fibroblasts in cardiac fibrosis, reference
the recent review by Travers et al.5
Fibroblast function is modulated by various receptors
and proteins on the cell surface, including ion channels,
macromolecular pores in the cell membrane that
allow selective fluxes of major ions K+, Ca2+, Na+ or
Cl- across the plasma membrane, affecting membrane
potential and cellular signal transduction. Ion
channels in excitable cardiac muscle cells have been
well studied and their role in cardiac physiology and
pathology well characterized. Of late, the importance
of ion channels in CFs, which are considered to be
nonexcitable cells, has emerged from recent studies
of cardiac pathophysiology using animal models
or human tissue. These studies have demonstrated
the role of ion channels in modulating various CF
functions such as proliferation, differentiation,
secretion and apoptosis.
www.aurora.org/jpcrr
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Understanding the contribution of different CF ion
channels to physiological responses to stress and their
alterations in pathological state may help facilitate
development of novel therapeutic strategies to limit
fibrosis and its adverse effects on myocardial function.
This narrative review summarizes the knowledge
gained thus far on ion channels in CFs and their
relationship with cardiac diseases in human and
experimental animal models.
Potassium (K+) Channels
Potassium channels are diverse and tightly regulated,
with high selectivity for K+ ion permeation. Across
plasma membranes of cells, K+ ions have negative
equilibrium potential, hence opening of K+ channels
tends to weaken excitation.6 K+ channels play various
roles in cellular functions, including stabilizing
membrane potentials, timing action potential durations
in excitable cells, spacing repetitive excitations,

and modulating membrane polarity, secretion and
contractility as mediated by receptors or intracellular
signaling. These channels can be identified by their
distinct gating characteristics.6 Many of the K+ channels
have been reported to play important role in CF
functions in healthy and disease states. A summary of
the role of K+ channels, along with other ion channels,
on different functions of CFs in humans is depicted in
Figure 1, while Table 17-29 reports findings from both
human and animal studies.
Voltage-Gated K+ (Kv) Channels: Kv channels are
highly sensitive to voltage changes across the plasma
membrane. Chamber-specific differential expression
of Kv currents is reported in canine CFs to have greater
density in the left ventricle than the left atrium.30
Downregulation of tetraethylammonium-sensitive Kv
current in atrial fibroblasts from a failing heart has
been reported in a canine tachypacing-induced heart

Figure 1. Functional regulation of human cardiac fibroblast by multiple ion channels. The (
) arrow indicates
facilitation; the ( ) symbol indicates inhibition/attenuation; and the (
) arrow indicates the H2O2-initiated
pathway. Transient receptor potential (TRP) channels include TRPC (“canonical”), TRPM (“melastatin”) and TRPA
(“ankyrin”). SOCE, store-operated Ca2+ entry; PKG, protein kinase G; BKCa, big-conductance Ca2+-activated
potassium channel; Kto, transient outward potassium channel; Cl-vol, volume-sensitive chloride channels; Nav1.5,
sodium channels (tetrodotoxin-resistant); TGFβ1, transforming growth factor type β1; TGFR, TGFβ1 receptor; H2S,
hydrogen sulphide; H2O2, hydrogen peroxide.
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failure model. This downregulation of Kv current was
reported to be beneficial. Mathematical modeling with
assumption of cardiomyocyte-fibroblast electrical
coupling demonstrated an antifibrillatory effect of
downregulated Kv currents facilitating termination of
electrical reentry by promoting atrial cardiomyocyte
depolarization, reduction in Na+ channel availability
and prolongation of action potential duration.15

However, how far these modeling-based predictions
with assumed fibroblast-cardiomyocyte electrical
coupling are operative in vivo remains to be determined;
in situ validations also are required. In vitro, fibroblast
proliferation was enhanced by pharmacological
suppression of Kv current, suggesting Kv channels
might negatively regulate fibroblast proliferation.30
Although it appears beneficial in terms of presumed

Table 1. Summary of Altered Ion Channel Functions in Human and Animal Cardiac Fibroblasts From Different
Cardiac Disease Models
Species

Ion channel

Condition/model

CF effect

Human

BKCa

Oxidative stress (H2O2)
Normal conditions

↑ apoptosis7
↑↓ proliferation8

TRPA1

Methylglyoxal (diabetic cardiomyopathy)

Activation of TRPA1 ↑ proliferation/
differentiation9

Clvol

Inhibition by DIDS

↓ proliferation8

ClCa (ANO1)

Activation by angiotensin II

↑ IClCa in atrial CF10

Ito (Kv4.3)

TGF-β1 activation (atrial)
H2S inhibition (atrial)

↑ Ito and differentiation11
Attenuates differentiation11

TRPC1

TGF-β1 administration

↑ TPRC1 expression12

TRPC6

TGF-β1 treatment

↑ TRPC6 expression12

TRPM7

AF patients, TGF-β1

↑ proliferation/differentiation13

Na (Nav1.5)

Atrial fibroblast

↑ differentiation14

Kv

Tachypacing-induced HF

↓ Kv currents (atrial CF)15

Kir

Tachypacing-induced HF

↑ Kir currents (atrial CF)16

IKCa

Pressure overload (aortic constriction)
Angiotensin II administration
Treatment with AGEs

↑ IKCa currents17
↑ IKCa expression18
↑ IKCa expression19

TRPC3

AF, heart failure

↑ TRPC3 expression20

TRPM2

Hypoxia

↑ TRPM2 currents21

TRPM7

Angiotensin II-induced fibrosis
TGF-β1 treatment

Initial ↑ and later ↓ currents22
↑ TRPM7 currents/proliferation/
differentiation22

TRPV1

TGF-β1-induced differentiation

Essential for differentiation; ↑ TRPV4
expression/Ca2+ influx23

L-type and
T-type Ca2+

TGF-β1 treatment

Smad2 phosphorylation24

KATP (Kir6.2)

Myocardial infarction

↑ Kir6.2 expression; affects injury zone
electrophysiology25

IKCa

Myocardial infarction

↑ KCa3.1 expression and fibrosis26

SUR2/Kir6.1

Activation by pinacidil

↑ ventricular CF proliferation; ↓ IL-6
secretion; active in transdifferentiation27

TRPC6

Ventricular pressure overload
TRPC6-deletion

↓ TRPC6 expression28
Impaired cardiac wound healing29

+

Dogs
Rats

Mice

AF, atrial fibrillation; AGEs, advanced glycation end products; CF, cardiac fibroblast; DIDS, 4,4'-diisothiocyano-2,2'stilbenedisulfonic acid; HF, heart failure.
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antifibrillatory effect, downregulation of Kv channels
also leads to increased proliferation of fibroblasts,30
which can be counter-productive as it can result in
increased fibrosis, a substrate for arrhythmogenesis.
Thus, the net effect of CF Kv channel downregulation/
expression, regulation and pharmacological modulation
on overall myocardial function, arrhythmogenesis and
scarring needs to be clarified in the normal and diseased
heart before any therapeutic strategies targeting Kv
channels can be formulated for limiting myocardial
fibrosis.
Ca2+-Activated K+ (KCa) Channels: KCa channels are
modulated by cytoplasmic free Ca2+ and classified
into three subtypes based on their single-channel
conductance: big conductance (BKCa), intermediate
conductance (IKCa), and small conductance (SKCa).
They also vary in their pharmacology, Ca2+ sensitivity
and voltage dependence.6
BKCa currents were found in most of the human
CFs31 and rat ventricular fibroblasts.32 These channels
positively regulate the cell cycle as their blockade by
paxilline suppressed proliferation of human CFs and
was mostly arrested at G0/G1 phase with decreased
expression of cyclin D1 and cyclin E,8 slowing down
the cell cycle progression. Interestingly, in conditions
associated with oxidative stress, BKCa channels can
evoke apoptosis of human CFs. Hydrogen peroxide
increases iberiotoxin-sensitive BKCa currents via the
protein kinase G pathway, resulting in apoptotic cell
injury.7 On one side, BKCa channels promote cell
cycle progression; on the other, they can also promote
apoptosis in cells under oxidative stress. Thus there
appears to be either a dual role played by the BKCa
channels themselves or additional molecular signaling
mechanisms involving these channels that might
become active under stress conditions.
IKCa channels, those of intermediate conductance, are
expressed in rat32 and mice26 ventricular fibroblasts.
In a mouse model of myocardial infarction, higher
expression of KCa3.1 in ventricular fibroblasts was
associated with excessive fibrosis and impaired
heart function,26 and pharmacological blockade of
KCa3.1 by TRAM-34 was shown in a rat model to
reduce pressure overload-induced fibrosis, which
could be alleviated by in vivo administration of
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TRAM-34 for 2 weeks.17 These observations suggest
that functional activation of IKCa channels promotes
cardiac fibrosis; however, its mechanistic basis
remains undefined.
Angiotensin II, a vasoactive peptide hormone,
also has been shown to increase the expression of
KCa3.1 channels via type 1 angiotensin II receptors
involving the extracellular signal-regulated kinase
1/2 (Erk1/2), p38 mitogen-activated protein kinase
(p38-MAPK)
and
phosphatidylinositol-3-kinase
(PI3K/Akt) signaling mediators with induction of
activator protein-1 complex in cultured rat CFs.18 In
vitro exposure of rat CFs to advanced glycation end
products (AGEs), which are glycated proteins or
lipids when exposed to hyperglycemic conditions
like diabetes, increases the expression of KCa3.1
channels and promotes fibroblast proliferation and
collagen synthesis through AGE receptor signaling via
phosphorylation of the Erk1/2, p38-MAPK and PI3K/
Akt signaling mechanisms.19 How changes in KCa3.1
gating, which effectively changes plasma membrane
polarity, alter the phosphorylation status of signaling
molecules in the Erk1/2–Akt pathway is puzzling. In
contrast, inhibition of IKCa channels in vitro is reported
to increase rat fibroblast proliferation,32 similar to Kv
channels in canine CFs.30
SKCa channels are expressed in rat ventricular
fibroblasts,32 however, their physiological importance
has yet to be elucidated.
Kir Channels: These channels belong to the inward
rectifier K+ channel family and show increased K+
conductance under hyperpolarization (favoring
K+ influx) and decreased conductance during
depolarization.6 Kir currents are reported in human
CFs,31 and Kir2.1 appears to be the primary ion channel
responsible for maintaining the resting membrane
potential of fibroblasts.33 Ba2+-sensitive Kir currents
were upregulated in canine atrial fibroblasts from
a tachypacing-induced heart failure model.15 Apart
from hyperpolarized resting membrane potential, left
atrial fibroblasts obtained from dogs with congestive
heart failure showed increased Kir currents and poreforming subunit KCNJ2 expression at both mRNA
and protein levels.16 Hyperpolarized membrane
potential caused by upregulation of Kir channels in
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fibroblasts also can increase the driving force for
Ca2+ entry through mechanisms like store-operated
Ca2+ entry (SOCE), thereby enhancing intracellular
Ca2+-dependent processes like secretion of profibrotic
factors, cytokines and collagen as well as promoting
fibroblast proliferation and facilitation of many
receptor-signaling pathways.16,34,35
SUR2/Kir6.1
Channels:
Pinacidil-activated
glibenclamide-sensitive K+ channels, which are
insensitive to intracellular adenosine triphosphate
(ATP), were found to become functional in mouse
ventricular fibroblasts culture when differentiation to
myofibroblasts occured. Activation of these currents
increases fibroblast proliferation but decreases
the secretion of the interleukin-6 cytokine.27
Endogenous phospholipid, sphingosine-1-phosphate
also can activate these channels.27 The mechanisms
by which these channels become functional during
the fibroblast transdifferentiation process are not
known. ATP-sensitive K+ currents (Kir6.2) are also
present in CFs,25 however, little is known about
their role in cardiac pathology. Attenuation of atrial
CF proliferation by sodium hydrogen sulphide
(an activator of KATP) following inhibition of KATP
channels by glibenclamide suggests that KATP
channels are less likely to play any role, at least
regarding proliferation.11
Kv4.3 Channels: Transient outward K+ currents
(Kv4.3) are present in human atrial fibroblasts.11 TGFβ1-induced fibroblast proliferation and differentiation
seems to be accompanied by increased expression of
Kv4.3, which could be attenuated by preincubation
with hydrogen sulphide, an endogenous gaseous
modulator of K+ channels.11 Acute exposure of atrial
fibroblasts to hydrogen sulphide facilitates steady-state
inactivation of Ito currents and attenuates recovery from
inactivation.11 Antagonizing Kv4.3 channels may be a
potential antifibrotic strategy to prevent the progression
of fibrosis, thereby decreasing the substrate for cardiac
dysfunctions like atrial fibrillation, cardiomyopathy
and heart failure.
Calcium (Ca ) Channels
The Ca2+ ion, a major second messenger in cellular
signaling mechanisms, can bind with high affinity to
several proteins and change their shape and charge and,
2+
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consequentially, change the corresponding protein’s
function.35 Several Ca2+ influx mechanisms are found
to exist in CFs.
SOCE channels: Store-operated Ca2+ channels are
highly Ca2+-selective plasma membrane channels
that get activated when endoplasmic reticulum
[Ca2+] declines. In a canine model of congestive
heart failure, left atrial fibroblasts showed increased
SOCE and proliferation.16 However, the mechanisms
involved in the increased SOCE in heart failure atrial
fibroblasts are not clear; although, hyperpolarized
resting membrane potential with increased Kir and
enhanced electrical driving force for Ca2+ entry has
been suggested as one possible mechanism.16 Several
SOCE pathways have been suggested, including
the Ca2+ release-activated channels (ICRAC) that are
comprised of plasmalemmal Orai1, the pore-forming
subunit, and STIM1, a regulatory subunit considered
to be the endoplasmic reticulum store’s Ca2+ sensor.36
The relative importance of changes in these subunits
in promoting cardiac fibrosis in different pathological
conditions is not clearly defined. Aging-related
decrease in SOCE and proliferation in rat glomerular
mesangial cells has been reported,37 provoking
interest on SOCE in aged human CFs.
L- and T-type Ca2+ Channels: These voltage-dependent
Ca2+ channels are predominant in excitable cells, where
their role in tissue excitability, excitation-contraction
coupling or secretion is well characterized. However,
despite demonstration of mRNA of the L-type and
T-type Ca2+ channels in nonexcitable cells like neonatal
rat CFs,24 their significance in fibroblast function is not
clear. TGF-β1-induced phosphorylation of Smad2 was
inhibited by combined L- and T-type channel block,
while neither L- nor T-type inhibition alone affected
the phosphorylation of Smad2.24 Further studies with
adult animal models and human CFs in physiological
and pathological conditions would throw more light
on these channels’ respective roles in the function of
nonexcitable cells.
Transient Receptor Potential (TRP) Channels
Several mammalian TRP channels have been identified
and are classified into six subfamilies based on amino
acid sequence homology: TRPC (canonical), TRPM
(melastatin), TRPV (vanilloid), TRPA (ankyrin),
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TRPML (mucolipin) and TRPP or PKD (polycystin).38
Of these, few types were detected functionally in CFs.
A summary of the functional role of various TRP
channels in CFs from humans is depicted in Figure 1
and Table 1, the latter of which includes observations
from various animal models.
TRPA1 Channels: TRPA1 channels are found to
be expressed in human CFs.9 Methylglyoxal, an
endogenous carbonyl compound produced under
hyperglycemic conditions, was found to activate
TRPA1 and enhance cell cycle progression and
fibroblast differentiation.9 Any change in the basal
expression or activity levels of TRPA1 channels in the
setting of cardiac disease conditions is not presently
known. It is probable that alterations are only at the
regulatory level of these channels by endogenous
ligands like methylglyoxal.
TRPC1 Channels: The TRPC channels permeate
for Ca2+ and Na+ ion influx.39 TGF-β1, a profibrotic
cytokine shown to be elevated in cardiac tissue
post-myocardial infarction,40 enhances mRNA/
protein expression of TRPC1 channels in human
CFs,12 suggesting participation of TRPC1 channels
in the cardiac fibrosis process. However, in rat CF
from atria and ventricles, immunohistochemistry
with fluorescence labeling against TRPC1 did not
detect any TRPC1 expression.41 It remains unknown
whether the expression of these channels is speciesdependent.
TRPC3 Channels: These channels are expressed in rat
CFs.20 Angiotensin II-induced Ca2+ influx, proliferation
in fibroblasts and differentiation to myofibroblasts
were suppressed by the TRPC3 blocker, pyrazole-3.
The expression of TRPC3 appears to be regulated by
microRNA-26, which has nuclear factor of activated T
cells (NFAT), a Ca2+-responsive transcriptional factor.
Binding sites in the 5' promoter region and NFAT
negatively regulated microRNA-26 transcription.
Moreover, NFAT activation is increased in fibroblasts
from a canine model of atrial fibrillation,20 which could
downregulate microRNA-26 and result in upregulation
of TRPC3 channels in atrial fibrillation conditions.
Further studies are warranted to validate this regulatory
pathway in human CFs.
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TRPC6 Channels: Ventricular fibroblasts are reported
to express TRPC6 channels.28 A genomewide screen
identified TRPC6 as necessary and sufficient for
myofibroblast transformation. Fibroblasts lacking
TRPC6 did not respond to TGF-β1- or angiotensin
II-induced transdifferentiation, and cardiac wound
healing was impaired in TRPC6-knockout mice.29
The profibrotic ligands TGF-β1 and angiotensin
II induced TRPC6 expression through p38-MAPK
serum response factor signaling via the TRPC6
promoter. Small interfering RNA knockdown of
TRPC6 reduced the diacylglycerol analogue OAG-,
thapsigargin- and angiotensin II-induced Ca2+ entry
in human CFs.12 TGF-β1 enhances mRNA/protein
expression of TRPC6 channels,12 which mediate
TGF-β1-induced myofibroblast transformation,
along with the calcineurin pathway. These TRPCmediated Ca2+ influx pathways were suggested to
activate the reverse-mode (Ca2+ influx) Na+/Ca2+
exchanger as well.12 In a mouse model of right
ventricular pressure overload, suppression of the
activity of endoglin, a co-receptor of TGF-β1,
attenuated TPRC6 activation and reversed cardiac
fibrosis.28 This also suggests that TRPC6 may be one
of the terminal signaling mechanisms of the TGF-β1
pathway, which plays an important part in the
progression of cardiac fibrosis. Several G proteincoupled receptors regulating activation of TRPC6
also has been reported. Endothelin-1 upregulates
TPRC6 channels in neonatal rat CFs via Gα12/13,
causing sustained Ca2+ influx and NFAT activation,
which, in turn, negatively influences myofibroblast
differentiation.42 C-type natriuretic peptide activates
TPRC6 channels through natriuretic peptide
receptor C via Gi- and phospholipase C-dependent
signaling.43
TRPM2 Channels: TRPM2 channels are functionally
expressed in rat CFs.21 Hypoxia enhances TRPM2
expression and increased clotrimazole-sensitive
(considered an inhibitor of the TRPM2 channel)
currents in cultured fibroblasts from an adult rat
heart. The functional status of TRPM2 channels in
human CF during hypoxic conditions like myocardial
ischemia or infarction has to be elucidated to
determine the translational significance of in vitro
hypoxic experimental observations.
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TRPM7 Channel: The TRPM7 channel is a
nonselective cation channel permeable to both Ca2+ and
Mg2+. Human atrial13 and rat CFs22 demonstrated ionic
currents with electrical and biophysical properties of
TRPM7 channels. Angiotensin II-induced proliferation,
apoptosis and fibrosis was associated with a timedependent initial increase –– and later fall –– of TRPM7
currents.22 TRPM7 protein expression increases by 24
hours in the presence of angiotensin II.44 Silencing
TRPM7 channels by short hairpin RNA interference
reduced hydrogen peroxide-induced activation of Ca2+
influx and 2-aminoethoxydiphenylborate, a TRPM7
blocker that could inhibit hydrogen peroxide-induced
cardiac fibrosis.28 In addition to Ca2+, another permeant
ion, Mg2+ –– an essential cofactor in numerous
enzymatic reactions via Mg2+-dependent regulation
of MAPK, tyrosine kinases, reactive oxygen species
and important signaling molecules –– is involved
in cell proliferation, differentiation, inflammation,
etc.45 TRPM7 channels, negatively regulated by
the endogenous phospholipid sphingosine,46 are
increased in atrial fibrillation patients and in vitro
TGF-β1-induced proliferation and differentiation to
myofibroblasts.13
TRPV1 Channels: Angiotensin II-induced proliferation
of mouse CFs was attenuated by dietary capsaicin, a
TRPV1 agonist, unlike in TRPV1-knockout mice.47
Activation of TRPV1 channels appears to be beneficial
in cardiac hypertrophy and results in reduced fibrosis;
however, the underlying mechanism remains unclear.
In an earlier study with a TRPV1-null mutant mice
model of myocardial infarction,48 TRPV1 ablation
showed upregulation of TGF-β1, MMP-2, Smad2
and collagen expression, with reduced left ventricular
ejection fraction and increased end-diastolic and
systolic diameters. Activation of TRPV1 expressed in
afferent nerve endings of the heart has been shown to
be beneficial to cardiac function following myocardial
infarction.48 This is interesting, as activation of afferent
nerve (TRPV1) signaling transmitted centrally to
the brain with a feedback efferent signal may help
contribute to the preservation of cardiac function after
myocardial infarction.
TRPV4
Channels:
Functional
TRPV4
49
channels were evident in rat CFs. 4α-phorbol
12,13-didecanoate, a selective TRPV4 agonist,
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was able to increase the [Ca2+]i by ruthenium redsensitive Ca2+ influx.49 TRPV4, considered to be a
mechanosensitive channel, is required for TGF-β1induced differentiation of CFs into myofibroblasts.
Ca2+ influx via TRPV4 channels is enhanced, with
increased expression of TRPV4 channels observed
following TGF-β1 treatment.23 Mechanosensitivity
of TRPV4 channels could play an important role in
cardiac remodeling, with altered chamber stiffness
resulting from increased differentiation of fibroblasts
to myofibroblasts that can further promote cardiac
fibrosis. More information on the physiological
and pathological role of TRPV4 channels in the
cardiovascular system is reported in a recent review
by Randhawa et al.50
Sodium (Na+) Channels
Nav1.5 (Tetrodotoxin [TTX]-Resistant) Channel:
Differentiated myofibroblasts from human atria
displayed fast inward voltage-gated Na+ current,
which was not detectable in undifferentiated atrial
fibroblasts14 with a large window current for potentials
between –100 and –20 mV.14 Interestingly, this
Nav1.5 channel expression was demonstrated to be a
de novo synthesis process during the myofibroblast
differentiation14 (Figure 1 and Table 1). An earlier
study showed rapidly inactivating TTX-resistant Na+
currents even in undifferentiated cultured human
CFs,31 which could be due to differences in culture
method/time, as differentiation can happen by
prolonged culture/passage.
TTX-Sensitive Na+ Channel: A slow, inactivated Na+
current with a persistent component sensitive to TTX
is also reported in human CFs,31 however its functional
role in CF under normal or disease conditions has yet
to be elucidated.
Chloride (Cl-) Channels
Cl-, the most abundant physiological anion –– distributed
as [Cl-]i < [Cl-]o with equilibrium potential ECl near the
resting membrane potential –– is involved in regulation
of intracellular pH, cell volume and secretion of fluids.6
Based on activation mechanisms, there are four classes
of Cl- channels: those activated by [Ca2+]i elevation,
membrane hyperpolarization, cell swelling or cAMPdependent phosphorylation,6 with only few studied
in CFs.
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Calcium-Dependent Cl- Channels (IClCa): Human
atrial fibroblasts were shown to have channels
with properties of calcium-dependent chloride
channels, activated by angiotensin II through its
type 1 receptors.10 It appears that anoctamin-1, a
transmembrane protein,51 contributes to this IClCa
current.10
Volume-Sensitive Cl Current (ICl,vol): Blockade of ICl.vol
with 100–200 μM of 4,4'-diisothiocyanatostilbene2,2'-disulfonic acid disodium (DIDS) significantly
reduced proliferation in human CFs,8 with cells
predominantly arrested at G0/G1 phase and
associated with decreased cyclin D1 and cyclin E
expressions.8
-

Conclusions and Future Directions
Several different ion channels expressed in cardiac
fibroblasts regulate cellular functions under normal
and diseased conditions and contribute to fibrosis and
arrhythmogenesis. The role of some of these channels,
such as TRPC1, TRPC6, TRPM7 and Na+ channels, in
human CF proliferation and differentiation as well as
BKCa channel in fibroblast proliferation or apoptosis
(depending on metabolic state), has been demonstrated;
yet, several questions remain unanswered. Although
TRPC6 is reported to be necessary and sufficient for
myofibroblast transformation,29 the existence of other
TRP channels, and their activation resulting in the
same effect, is puzzling. Whether there is any crosstalk between these channels or any intermediary
signaling mechanisms to coordinate the function is
unclear. Activation of most TRP channels increases
intracellular [Ca2+]i, which can influence multiple
signaling mechanisms –– including activation of
BKCa, Cl-, and intracellular Ca2+ release –– which in
turn could modulate various cellular functions like
proliferation, gene transcription and secretion.
Human studies indicate that the functional effect of
ion channel alterations may depend on the cellular
metabolic stress, as in the redox state of CFs (e.g.
pro-apoptotic vs pro-proliferative effect of BKCa
channels). Therefore, defining the potential role of
each ion channel in CF function remains challenging
and needs to be carefully elucidated under various
pathophysiological conditions that are further
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compromised by aging and disease (hyperglycemia,
pressure or volume overload, metabolic stress, etc.)
before they can be considered as potential targets for
the prevention of adverse cardiac remodeling and
progression of cardiac dysfunction.
Patient-Friendly Recap
• As people age, their heart tissue gradually
becomes scarred due to the ability of fibroblast
cells to heal heart injury.
• Unfortunately, too much scarring eventually
contributes to heart dysfunction so cardiac
fibroblasts may need to be slowed or deactivated
in older patients.
• The authors reviewed the literature to further
understand the role certain proteins called ion
channels play on cardiac fibroblast production
under various states of health.
• A better understanding of these ion channels
could lead to novel therapies that limit heart
scarring.
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